PDGFRA and central nervous system cancer: We observed Pdgfra amplification in 9 of the 15 lines derived from tumor-bearing mice, including all 5 lines from mice bearing advanced gliomas, and 4 lines from mice bearing early stage gliomas (Fig. 3a).